2020 IPO
SQZ Biotech Stock
SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies.
Sign up today and learn more about SQZ Biotech Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About SQZ Biotech Stock
SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.
Investors
NanoDimension
Funding History
April 2014 | $15K |
---|---|
October 2014 | $100K |
June 2015 | $5.0M |
September 2016 | $16.0M |
December 2016 | $8.3M |
August 2018 | $72.0M |
Management
Director of Strategic Scientific Partnerships
Jonathan Gilbert
CEO
Armon Sharei
Chief Scientific Officer
Howard Bernstein